West Nile Virus in Horses, sub-Saharan Africa by Cabre, Olivier et al.
West Nile Virus 
in Horses,
sub-Saharan Africa 
Olivier Cabre,* Marc Grandadam,† 
Jean-Lou Marié,‡ Patrick Gravier,† 
Aurélie Prangé,† Yan Santinelli,§ Vincent Rous,¶
Olivier Bourry,# Jean-Paul Durand,† 
Hugues Tolou,† and Bernard Davoust**
To evaluate the presence and extension of West Nile
virus where French soldiers are stationed in Africa, specif-
ic antibody prevalence was determined by using ELISAand
Western blot. Among 245 horses living in close proximity to
the soldiers, seroprevalence was particularly high in Chad
(97%) and Senegal (92%).
W
est Nile virus (WNV), a mosquito-transmitted fla-
vivirus, was first isolated in Africa, West Nile dis-
trict of Uganda, in 1937 (1). It has been shown to infect
humans and a wide spectrum of animal species, including
birds and horses. WNV infection is often inapparent or
mild in humans but may cause severe and even fatal
encephalitis in horses (2). Since 1999, dissemination of the
virus through North America has reinforced interest in
WNV epidemiology and evolution. Before 1999, out-
breaks have been reported in North Africa, Israel,
Romania, Russia, and France, where the virus may have
been imported by migratory birds (3–5). However, few
data are available on the current circulation of WNV in
sub-Saharan Africa because of lack of surveillance and
diagnostic tools in those countries.
Assessing and preventing human and zoonotic infec-
tious diseases in tropical areas, particularly Africa, are
essential missions of the French Defense Medical Service.
To evaluate the presence and extension of WNVin the sub-
Saharan African areas where French soldiers are stationed,
serologic surveillance of horses living in close proximity
was initiated in 2002.
The Study
From December 2002 through August 2005, blood
samples were collected from 245 horses in 13 riding sta-
bles located in Senegal (Dakar, n = 25), Côte d’Ivoire
(Abidjan, n = 95), Chad (N’Djamena, n = 30), Democratic
Republic of the Congo (Kinshasa, n = 20), Gabon
(Libreville, Port Gentil, and Moanda, n = 64), and Djibouti
(Djibouti, n = 11) (Figure 1). Some horses were sampled
twice in Chad (n = 18) and in Côte d’Ivoire (n = 18) dur-
ing a period of 11–13 months. Origin, travel history, and
how long the tested horses lived in the studied areas were
not well known, but the horses were generally born and
bred in the countries from which they were sampled (some
of them in neighboring countries such as Burkina Faso,
Mali, Niger, and Ethiopia), and none had a history of
WNV vaccination.
Blood was centrifuged within 24 hours after collection.
Serum was separated, frozen at –20°C, and sent to the
virology laboratory of the Institut de Médecine Tropicale
du Service de Santé des Armées in Marseille, France. Each
sample was systematically tested for WNV-specific
immunoglobulin G (IgG) by using an ELISA made in
house. Antigen was prepared from a crude supernatant of
Vero cells collected after 4 days of infection with WNV
reference strain Eg 101 (viral titer >107 ID/mL) and treat-
ed with 1% Triton 100 and β-propiolactone (1:1,000). IgG
was detected by using commercial peroxidase anti-horse
IgG and tetramethylbenzidine as the substrate and standard
procedures of ELISAcapture. Serum specimens were con-
sidered positive for IgG when the optical density (OD) in
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Figure 1. West Nile virus (WNV) circulation in Africa (3,6–10). Map
of Africa summarizes published data related to WNV isolations,
outbreaks, and sporadic or serologic cases (including this study).
It also indicates the main bird migration routes (source: Wetlands
International, Wageningen, the Netherlands). Source: Food and
Agricultural Organization of the United Nations.antigen-positive wells was >0.3 and the ratio between the
OD in corresponding antigen-positive wells and the mean
OD in antigen-negative wells was >3.5. Because of the
antigenic cross-reactivity among viruses of the Flavivirus
genus, validation of ELISAIgG–positive samples was nec-
essary. The plaque reduction neutralization test (PRNT) is
the serologic reference method. All the IgG-positive sera
collected during 2002–2003 were tested as described (11).
In a 96-well plate, 4 dilutions of each serum sample (1:10,
1:40, 1:160, 1:640; 4 wells for each dilution) were incubat-
ed at 37°C for 1 hour in a viral suspension of 10–50 PFU
in 50 µL before the addition of 100 µL of a Vero cell sus-
pension (4×104/well). Four days later, the cell layer was
fixed in formol and stained with crystal violet. Atest result
was considered positive for a dilution if the plaque reduc-
tion was >90% compared with the negative control.
Because this method is fastidious and slow, we have used
an alternative Western blot (WB) approach as described in
Figure 2 (12).
Complete (100%) correlation between WB and PRNT
and high specificity of WB were observed for a panel of 79
serum samples. Thus, only WB was used for validation of
ELISA IgG-positive sera for the 2004–2005 samples. All
serum samples that were positive for WNV IgG were fur-
ther investigated using immunocapture IgM ELISA to
evaluate the time of infection.
Conclusions
Except in Gabon (3%), high seroprevalence
(28%–97%) for WNV was detected in horses in West
Africa and Central Africa, especially in N’Djamena (97%)
and Dakar (92%) (Table 1). Seroprevalence of 9% was
detected in East Africa (Djibouti).
All horses positive for IgG were negative for IgM,
which indicates relatively old infection. Estimating the date
of onset of WNV infection is difficult because of a lack of
published data relative to WNV IgM and IgG response in
naturally infected horses; only persistence of IgG several
years after infection has been described (4). Because histo-
ries of tested horses are not well known, determining pre-
cisely when and where horses became infected is difficult.
However, infections likely occurred in sampling countries
or neighboring sub-Saharan African countries.
Seroconversion from negative to positive was found in
2 horses in Chad (Table 2) from 2003 through 2004, while
5 of 15 seropositive horses became seronegative, which
suggests maintenance of an enzootic cycle in this area but
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Figure 2. West Nile virus (WNV) Western blot as a validation of
ELISA-positive results. Proteins from WNV-infected cells lysates
were separated by sodium dodecyl sulfate–polyacrylamide gel
electrophoresis on 13% acrylamide gels and transferred on
polyvinylidene difluoride membranes. Strips were cut and blocked
with nonfat milk (5%). Serum samples diluted (1:200) in phos-
phate-buffered saline (PBS), 5% nonfat milk, and 0.1% Tween 20
were loaded on strips and incubated for 1 h with slow shaking.
Strips were washed 4 times in PBS, 0.5% Tween, and incubated
for 1 h  in anti-horse immunoglobulin G (IgG) peroxidase (1:
8,000). After 4 washes, Western blots were incubated for 5 min
with trimethylbenzidine substrate (with specific enhancers). Strips
were washed once with water to stop the staining. Results were
obtained within 24 h. MW, molecular weight; T+, horse from Chad
with positive Western blot results; serum samples 1–11, horse
from southeast France, IgG positive by ELISA but negative by
neutralization; NS5, nonstructural protein 5; E, envelope; PreM,
premembrane; C, capsid.at a low level. During the same period in Côte d’Ivoire, 9
of 10 previously seropositive horses were seronegative,
while none of seronegative horses became seropositive.
The most probable explanation is a decrease in IgG titer
under the retained threshold of positivity compatible with
the decrease of WNV IgG response in horses, which sug-
gests the presence of an older epizootic in this area.
The immunoblotting method is a fast and specific con-
firmation assay for validation of ELISA WNV IgG–posi-
tive sera. Once validated by further studies, WB could be
used as an alternative to PRNT.
Serologic data from our study should be considered as
evidence of WNV activity in sub-Saharan Africa, which
has a potential risk for populations and foreigners, includ-
ing French soldiers. Previously, WNV was known to circu-
late in mosquitoes and some bird species without having
any clear pathogenicity; outbreaks have been reported only
in South Africa and in the Democratic Republic of the
Congo (5,6). Before our study, no data relative to WNV
circulation in horses in sub-Saharan Africa were docu-
mented, and WNV activity had never been reported in
Chad or Gabon.
Highest (92%–97%) seroprevalence was found in the
western and central parts of the Sahelian area (Dakar and
N’Djamena). This area, characterized by a semiarid cli-
mate and vegetation of steppe and brush grass, is the most
frequently involved area for WNV isolations in birds and
mosquitoes (7,13). The seroprevalence was lower in the
east of the Sahelian area (Djibouti, 9%), where the climate
is arid and the vegetation is semidesert, and in the sub-
Sahelian area (3%–30%), where the vegetation is tropical
rain forest or woodland savanna in a humid or semihumid
climate. That forest favors the sedentariness of birds has
been documented (14). The migration of birds may cer-
tainly be enhanced in the Sahelian area; the introduction of
WNV by migratory birds during their flight between
Senegal and Europe has been suspected as a cause of the
1996 outbreak in Morocco (10). To estimate possibilities
of incursions of WNV, especially in Eurasia, effects of
environmental factors such as climate and vegetation on
reservoir and vector populations in sub-Saharan Africa
should be precisely studied. 
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